Entera Bio Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Entera Bio Ltd., a foreign private issuer, covers the month of November 2020. The report, dated November 30, 2020, consists solely of a press release issued on that date, which is attached as Exhibit 99.1 and incorporated by reference. The registrant is based in Jerusalem, Israel, and files annual reports on Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a vehicle to distribute a press release and does not contain audited financial statements or specific financial data points within the provided text.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. No comparative financial data or operational metrics are included in the cover document.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. While the filing incorporates a press release by reference, the specific content of that release is not detailed in the provided text.
Key Facts for Investor Verification
- Verify the specific content of the press release dated November 30, 2020, attached as Exhibit 99.1, as the cover letter contains no operational details.
- Confirm the incorporation of this report into Registration Statements on Form F-3 (Numbers 333-238988 and 333-239843).
- Note that this filing is a procedural report of a foreign private issuer and does not include standalone financial data.